Announcements from Department of Health

Please note the following announcements from the Drug Office of Department of Health:

• Important information on Gliolan (5-aminolevulinic acid): What to do in case of delayed surgery and information on fluorescence in non high-grade glioma
• Tecentriq (atezolizumab): Assessing the Potential Risk of Autoimmune Hemolytic Anemia
• Sofosbuvir-containing products: Assessing the Potential Risk of Severe Cutaneous Adverse Reactions